Highlander Capital Management’s ELITE PHARMACEUTICAL ELI Stock Holding History

Highlander Capital Management’s Portfolio ELI Stock Details ELI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-50,000	Closed	-$4K	–	648
2020 Q1	$4K	Hold	50,000	–	–	﹤0.01%	560
2019 Q4	$5K	Hold	50,000	–	–	﹤0.01%	566
2019 Q3	$4K	Hold	50,000	–	–	﹤0.01%	605
2019 Q2	$2K	Hold	50,000	–	–	﹤0.01%	656
2019 Q1	$5K	Hold	50,000	–	–	﹤0.01%	619
2018 Q4	$4K	Hold	50,000	–	–	﹤0.01%	635
2018 Q3	$5K	Hold	50,000	–	–	﹤0.01%	654
2018 Q2	$5K	Buy	+50,000	New	+$5K	﹤0.01%	675

Other funds holding ELI

CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return

Highlander Capital Management's ELI Position: Q2 2020 in Review

Highlander Capital Management sold out of ELITE PHARMACEUTICAL (ELI) in Q2 2020, closing a stake of 50,000 shares — an estimated $4K sold.

Highlander Capital Management first reported a position in ELI in Q2 2018 and held it in 8 quarters. The position peaked at $5K in Q4 2019. 1 fund tracked by Wall St. Rank holds ELI as of Q2 2020.

Highlander Capital Management reported no remaining ELITE PHARMACEUTICAL position as of Q2 2020 after selling out during the quarter.
Highlander Capital Management sold 50,000 ELITE PHARMACEUTICAL shares in Q2 2020, an estimated $4K.
Highlander Capital Management first reported a position in ELITE PHARMACEUTICAL in Q2 2018 and held it in 8 quarters.
Highlander Capital Management's ELITE PHARMACEUTICAL position peaked at $5K in Q4 2019.
1 fund tracked by Wall St. Rank held ELITE PHARMACEUTICAL as of Q2 2020.

Based on Highlander Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.